ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Physician Assistant

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,456Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 170

$360K Total Retail Price of All Prescriptions

Rank: 6 out of 170

261 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
48% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 261 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

18% of this provider’s 261 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 5,901 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
LISINOPRIL 274 204 1 4
FUROSEMIDE 244 215 2 6
SIMVASTATIN 225 198 3 3
HYDROCODONE-ACETAMINOPHEN 225 135 S3 3 1
OMEPRAZOLE 201 162 5 5
AMLODIPINE BESYLATE 200 182 6 7
POTASSIUM CHLORIDE 200 180 6 8
LEVOTHYROXINE SODIUM 182 134 8 2
DONEPEZIL HCL 144 144 9 40
PRAVASTATIN SODIUM 137 124 10 17
LOSARTAN POTASSIUM 136 127 11 18
METOPROLOL SUCCINATE 118 77 12 23
TAMSULOSIN HCL 114 99 13 30
WARFARIN SODIUM 105 61 14 11
GABAPENTIN 104 83 15 10
TRAMADOL HCL 103 96 16 12
LISINOPRIL-HYDROCHLOROTHIAZIDE 99 99 17 27
ATENOLOL 93 75 18 16
ATORVASTATIN CALCIUM 93 67 18 25
METFORMIN HCL 88 72 20 9
SERTRALINE HCL 80 80 21 21
ALENDRONATE SODIUM 78 78 22 32
METFORMIN HCL ER 78 68 22 49
ZOLPIDEM TARTRATE 77 53 24 22
HYDROCHLOROTHIAZIDE 76 67 25 13
FAMOTIDINE 72 56 26 54
CYCLOBENZAPRINE HCL 68 32 R 27 33
CYMBALTA 65 42 28 45
CITALOPRAM HBR 65 62 28 15
METOPROLOL TARTRATE 63 55 30 14
PANTOPRAZOLE SODIUM 61 50 31 54
LANTUS 61 49 31 41
CARVEDILOL 59 56 33 35
NAMENDA 58 58 34 48
CLOPIDOGREL 57 48 35 39
FLUTICASONE PROPIONATE 57 47 35 19
DOXYCYCLINE HYCLATE 56 40 37 68
MIRTAZAPINE 56 45 37 59
PROAIR HFA 53 16 39 51
CELEBREX 50 23 40 107
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 7, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.